Biomaterial Database

Treatment of glomerulonephritis (GN) with anticoagulants (AC), immunosuppressors (IS) and corticosteroids (CS). 1985

N Belovezhdov, and I Altunkova

UI	MeSH Term	Description	Entries
D011239	Prednisolone	A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.	Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D004359	Drug Therapy, Combination	Therapy with two or more separate preparations given for a combined effect.	Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005921	Glomerulonephritis	Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.	Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925	Anticoagulants	Agents that prevent BLOOD CLOTTING.	Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D001379	Azathioprine	An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)	Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

N Belovezhdov, and I Altunkova

[Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors].

January 1985, Vutreshni bolesti,

N Belovezhdov, and I Altunkova

[Treatment of idiopathic membranous glomerulonephritis with steroids and immunosuppressors].

January 2000, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,

N Belovezhdov, and I Altunkova

[Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].

January 1984, Vutreshni bolesti,

N Belovezhdov, and I Altunkova

Effect of immunosuppressors, anticoagulants and antiphlogistic drugs on experimental Masugi glomerulonephritis: I-imuran.

January 1976, Polish medical sciences and history bulletin,

N Belovezhdov, and I Altunkova

The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC).

November 2023, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

N Belovezhdov, and I Altunkova

[Treatment of chronic glomerulonephritis with heparin and anticoagulants].

October 1974, Nihon rinsho. Japanese journal of clinical medicine,

N Belovezhdov, and I Altunkova

[Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].

March 1987, Vrachebnoe delo,

N Belovezhdov, and I Altunkova

[Mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and chronic hepatitis C. Sequential treatment with immunosuppressors and interferon].

January 1994, Medicina clinica,

N Belovezhdov, and I Altunkova

[Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants].

January 1986, Vutreshni bolesti,